L'Oreal to pay $1.2 mil. punitive fine for breach of minoxidil/retinoid licensing agreement.
This article was originally published in The Rose Sheet
MINOXIDIL LAWSUIT JURY AWARDS ALYZAN $1.2 MIL. FOR BREACH OF CONTRACT, anticipatory repudiation of contract, and breach of implied duty of good faith, fair dealing and cooperation with regard to Alyzan's exclusive licensing agreement with L'Oreal for rights to the development, regulatory approval and commercial sale of Alyzan's prescription minoxidil/retinoid compound hair regrowth formulas. The suit, filed in Manhattan federal court Oct. 14, 1993 by Alyzan President and CEO Gail Bazzano, was decided in favor of Alyzan and Bazzano by a jury Oct. 31. Bazzano developed the formulas.
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review